Ann: Interview - Corporate Update, page-80

First 80 Last

Share
Profile

Follow
Arranging

4,435 Posts.

40

05/02/21

21:23

Post #: 50753952
Share

Originally posted by globetrotter79: ↑

Totally agree with your theory Grandslam, there will be pressure from international community which will without a doubt cause issues when trying to get funding.

I spent 11yrs working for one of the biggest banks (only left ~18months ago) in the world and most of that time was spent working in their global co
mmercial banking department. I can say with confidence that because of pressure from regulators any corporate transactions in/with Myanmar will be red flagged. Australian domestic banks and the large internationals will stear clear.

I'm not bagging MYL and I was a holder until the last little spike and I would consider buying back when this government thing is cleared up or take a tiny 'through away' position if the price tanks to ~ 0.01c.
But every share holder should be aware of the risk here if Myanmar ends up on a sanctions list again.....financing will be almost impossible.

Best of luck to all share holders, I really hope my worst fears are not realised.

Expand

Why wouldn't the Myanmar Government not fund it? joint partnership?

I don't think this has been suggested before, half a million USA $ is bugger all for the Myanmar Government

I think Australians think this country is very 3rd world, sure its not a wealthy nation by any means, but any Govt can fund this project with ease.

Last edited by Arranging: 05/02/21

MYL Price at posting: 7.0¢ Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 170 more messages in this thread...

First 80 Last

Add MYL (ASX) to my watchlist

Ann: Interview - Corporate Update, page-80

Top Stories

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News